Recombinant Human Albumin?(rHu?Albumin) is an animal component-free and?serum-free product that is structurally equivalent to native?human serum albumin?(HSA). It is manufactured without the use of animal- or?human-derived materials.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Recombinant Human Serum Albumin industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
2ml
5ml
Others
Market Segment by Product Application
Medicine
Scientific Research
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Takeda
Cyagen Biosciences
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Recombinant Human Serum Albumin consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Recombinant Human Serum Albumin market by identifying its various subsegments.
3.Focuses on the key global Recombinant Human Serum Albumin manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Recombinant Human Serum Albumin with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Recombinant Human Serum Albumin submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Recombinant Human Serum Albumin Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Recombinant Human Serum Albumin Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Recombinant Human Serum Albumin Segment by Type
2.1.1 2ml
2.1.2 5ml
2.1.3 Others
2.2 Market Analysis by Application
2.2.1 Medicine
2.2.2 Scientific Research
2.2.3 Others
2.3 Global Recombinant Human Serum Albumin Market Comparison by Regions (2017-2027)
2.3.1 Global Recombinant Human Serum Albumin Market Size (2017-2027)
2.3.2 North America Recombinant Human Serum Albumin Status and Prospect (2017-2027)
2.3.3 Europe Recombinant Human Serum Albumin Status and Prospect (2017-2027)
2.3.4 China Recombinant Human Serum Albumin Status and Prospect (2017-2027)
2.3.5 Japan Recombinant Human Serum Albumin Status and Prospect (2017-2027)
2.3.6 Southeast Asia Recombinant Human Serum Albumin Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Recombinant Human Serum Albumin Industry Impact
2.5.1 Recombinant Human Serum Albumin Business Impact Assessment - Covid-19
2.5.2 Market Trends and Recombinant Human Serum Albumin Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Recombinant Human Serum Albumin Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Recombinant Human Serum Albumin Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Recombinant Human Serum Albumin Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Recombinant Human Serum Albumin Manufacturer Market Share
3.5 Top 10 Recombinant Human Serum Albumin Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Recombinant Human Serum Albumin Market
3.7 Key Manufacturers Recombinant Human Serum Albumin Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Recombinant Human Serum Albumin Industry Key Manufacturers
4.1 Boehringer Ingelheim
4.1.1 Compan Detail
4.1.2 Boehringer Ingelheim Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.1.3 Boehringer Ingelheim 166 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Boehringer Ingelheim News
4.2 Bristol-Myers Squibb
4.2.1 Compan Detail
4.2.2 Bristol-Myers Squibb Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.2.3 Bristol-Myers Squibb Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Boehringer Ingelheim News
4.3 Celldex Therapeutics
4.3.1 Compan Detail
4.3.2 Celldex Therapeutics Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.3.3 Celldex Therapeutics Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Celldex Therapeutics News
4.4 Eli Liily
4.4.1 Compan Detail
4.4.2 Eli Liily Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.4.3 Eli Liily Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Eli Liily News
4.5 GlaxoSmithKline
4.5.1 Compan Detail
4.5.2 Eli Liily Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.5.3 GlaxoSmithKline Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 GlaxoSmithKline News
4.6 Merck
4.6.1 Compan Detail
4.6.2 Merck Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.6.3 Merck Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Merck News
4.7 Novartis
4.7.1 Compan Detail
4.7.2 Novartis Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.7.3 Novartis Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Regeneron Pharmaceuticals
4.8.1 Compan Detail
4.8.2 Regeneron Pharmaceuticals Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.8.3 Regeneron Pharmaceuticals Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Regeneron Pharmaceuticals News
4.9 Roche
4.9.1 Compan Detail
4.9.2 Roche Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.9.3 Roche Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Roche News
4.10 Takeda
4.10.1 Compan Detail
4.10.2 Takeda Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.10.3 Takeda Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Takeda News
4.11 Cyagen Biosciences
4.11.1 Compan Detail
4.11.2 Cyagen Biosciences Recombinant Human Serum Albumin Product Introduction, Application and Specification
4.11.3 Cyagen Biosciences Recombinant Human Serum Albumin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Cyagen Biosciences News
5 Global Recombinant Human Serum Albumin Market Segment by Big Type
5.1 Global Recombinant Human Serum Albumin Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Recombinant Human Serum Albumin Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Recombinant Human Serum Albumin Revenue and Market Share by Big Type (2017-2022)
5.2 2ml Sales Growth Rate and Price
5.2.1 Global 2ml Sales Growth Rate (2017-2022)
5.2.2 Global 2ml Price (2017-2022)
5.3 5ml Sales Growth Rate and Price
5.3.1 Global 5ml Sales Growth Rate (2017-2022)
5.3.2 Global 5ml Price (2017-2022)
5.4 Others Sales Growth Rate and Price
5.4.1 Global Others Sales Growth Rate (2017-2022)
5.4.2 Global Others Price (2017-2022)
6 Global Recombinant Human Serum Albumin Market Segment by Big Application
6.1 Global Recombinant Human Serum Albumin Sales Market Share by Big Application (2017-2022)
6.2 Medicine Sales Growth Rate (2017-2022)
6.3 Scientific Research Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Recombinant Human Serum Albumin Forecast
7.1 Global Recombinant Human Serum Albumin Revenue, Sales and Growth Rate (2022-2027)
7.2 Recombinant Human Serum Albumin Market Forecast by Regions (2022-2027)
7.2.1 North America Recombinant Human Serum Albumin Market Forecast (2022-2027)
7.2.2 Europe Recombinant Human Serum Albumin Market Forecast (2022-2027)
7.2.3 China Recombinant Human Serum Albumin Market Forecast (2022-2027)
7.2.4 Japan Recombinant Human Serum Albumin Market Forecast (2022-2027)
7.2.5 Southeast Asia Recombinant Human Serum Albumin Market Forecast (2022-2027)
7.2.6 Other Regions Recombinant Human Serum Albumin Market Forecast (2022-2027)
7.3 Recombinant Human Serum Albumin Market Forecast by Type (2022-2027)
7.3.1 Global Recombinant Human Serum Albumin Sales Forecast by Type (2022-2027)
7.3.2 Global Recombinant Human Serum Albumin Market Share Forecast by Type (2022-2027)
7.4 Recombinant Human Serum Albumin Market Forecast by Application (2022-2027)
7.4.1 Global Recombinant Human Serum Albumin Sales Forecast by Application (2022-2027)
7.4.2 Global Recombinant Human Serum Albumin Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Recombinant Human Serum Albumin Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Recombinant Human Serum Albumin Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Recombinant Human Serum Albumin
Figure Market Concentration Ratio and Market Maturity Analysis of Recombinant Human Serum Albumin
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Recombinant Human Serum Albumin Market Size by Big Type
Figure Global Market Share of Recombinant Human Serum Albumin by Big Type in 2021
Figure 2ml Picture (2017-2022)
Figure 5ml Picture (2017-2022)
Global Recombinant Human Serum Albumin Market Size by Big Application
Table Global Recombinant Human Serum Albumin Market Size by Application
Figure Global Recombinant Human Serum Albumin Market Share by Big Application in 2021
Figure Medicine Picture
Figure Scientific Research Picture
Figure Others Picture
Table Global Recombinant Human Serum Albumin Comparison by Regions (M USD) (2017-2027)
Figure Global Recombinant Human Serum Albumin Market Size (Million US$) (2017-2027)
Figure North America Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate (2017-2027)
Figure China Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Recombinant Human Serum Albumin Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Recombinant Human Serum Albumin Sales by Manufacturer (2017-2022)
Figure Global Recombinant Human Serum Albumin Sales Market Share by Manufacturer in 2021
Table Global Recombinant Human Serum Albumin Revenue by Manufacturer (2017-2022)
Figure Global Recombinant Human Serum Albumin Revenue Market Share by Manufacturer in 2021
Table Global Recombinant Human Serum Albumin Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Recombinant Human Serum Albumin Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Recombinant Human Serum Albumin Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Recombinant Human Serum Albumin Market
Table Key Manufacturers Recombinant Human Serum Albumin Product Type
Table Mergers & Acquisitions Planning
Table Boehringer Ingelheim Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Boehringer Ingelheim
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bristol-Myers Squibb Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Recent Development
Table Celldex Therapeutics Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Celldex Therapeutics
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celldex Therapeutics Main Business
Table Celldex Therapeutics Recent Development
Table Eli Liily Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Eli Liily
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Liily Main Business
Table Eli Liily Recent Development
Table Eli Liily Main Business
Table Eli Liily Recent Development
Table GlaxoSmithKline Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of GlaxoSmithKline
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Merck Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Merck
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Novartis Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Novartis
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Regeneron Pharmaceuticals Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Regeneron Pharmaceuticals
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Regeneron Pharmaceuticals Main Business
Table Regeneron Pharmaceuticals Recent Development
Table Roche Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Roche
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Takeda Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Takeda
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Takeda Main Business
Table Takeda Recent Development
Table Cyagen Biosciences Company Profile
Table Recombinant Human Serum Albumin Product Introduction, Application and Specification of Cyagen Biosciences
Table Recombinant Human Serum Albumin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cyagen Biosciences Main Business
Table Cyagen Biosciences Recent Development
Figure Global Recombinant Human Serum Albumin Sales and Growth Rate (2017-2022)
Figure Global Recombinant Human Serum Albumin Revenue and Growth Rate (2017-2022)
Table Global Recombinant Human Serum Albumin Sales by Regions (2017-2022)
Figure Global Recombinant Human Serum Albumin Sales Market Share by Regions in 2021
Table Global Recombinant Human Serum Albumin Revenue by Regions (2017-2022)
Figure Global Recombinant Human Serum Albumin Revenue Market Share by Regions in 2021
Figure North America Recombinant Human Serum Albumin Sales and Growth Rate (2017-2022)
Figure Europe Recombinant Human Serum Albumin Sales and Growth Rate (2017-2022)
Figure China Recombinant Human Serum Albumin Sales and Growth Rate (2017-2022)
Figure Japan Recombinant Human Serum Albumin Sales and Growth Rate (2017-2022)
Figure Southeast Asia Recombinant Human Serum Albumin Sales and Growth Rate (2017-2022)
Figure Other Regions Recombinant Human Serum Albumin Sales and Growth Rate (2017-2022)
Table Global Recombinant Human Serum Albumin Sales by Big Type (2017-2022)
Table Global Recombinant Human Serum Albumin Sales Market Share by Big Type (2017-2022)
Figure Global Recombinant Human Serum Albumin Sales Market Share by Big Type in 2019
Table Global Recombinant Human Serum Albumin Revenue by Big Type (2017-2022)
Table Global Recombinant Human Serum Albumin Revenue Market Share by Big Type (2017-2022)
Table Global Recombinant Human Serum Albumin Revenue Market Share by Big Type in 2019
Figure Global 2ml Sales Growth Rate (2017-2022)
Figure Global 2ml Price (2017-2022)
Figure Global 5ml Sales Growth Rate (2017-2022)
Figure Global 5ml Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Recombinant Human Serum Albumin Sales by Big Application (2017-2022)
Table Global Recombinant Human Serum Albumin Sales Market Share by Big Application (2017-2022)
Figure Global Recombinant Human Serum Albumin Sales Market Share by Big Application in 2019
Figure Global Medicine Sales Growth Rate (2017-2022)
Figure Global Scientific Research Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Recombinant Human Serum Albumin Sales and Growth Rate (2022-2027)
Figure Global Recombinant Human Serum Albumin Revenue and Growth Rate (2022-2027)
Table Global Recombinant Human Serum Albumin Sales Forecast by Regions (2022-2027)
Table Global Recombinant Human Serum Albumin Market Share Forecast by Regions (2022-2027)
Figure North America Sales Recombinant Human Serum Albumin Market Forecast (2022-2027)
Figure Europe Sales Recombinant Human Serum Albumin Market Forecast (2022-2027)
Figure China Sales Recombinant Human Serum Albumin Market Forecast (2022-2027)
Figure Japan Sales Recombinant Human Serum Albumin Market Forecast (2022-2027)
Figure Southeast Asia Sales Recombinant Human Serum Albumin Market Forecast (2022-2027)
Figure Other Regions Sales Recombinant Human Serum Albumin Market Forecast (2022-2027)
Table Global Recombinant Human Serum Albumin Sales Forecast by Type (2022-2027)
Table Global Recombinant Human Serum Albumin Market Share Forecast by Type (2022-2027)
Table Global Recombinant Human Serum Albumin Sales Forecast by Application (2022-2027)
Table Global Recombinant Human Serum Albumin Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Serum Albumin
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Recombinant Human Serum Albumin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Recombinant Human Serum Albumin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Recombinant Human Serum Albumin Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Recombinant Human Serum Albumin Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Recombinant Human Serum Albumin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)